Axsome Therapeutics Highlights Innovative Neuroscience Portfolio at the American Academy of Neurology (AAN) 2024 Annual Meeting
GlobeNewswire
AXS-05 in Alzheimer’s disease agitation data featured in oral plenary sessionNew data for AXS-07 in migraine demonstrating..